Vested Partners With Tenacity and a Personal Commitment to You

As technology continues to rapidly evolve, opportunities for pharma also increase when it comes to patient data. The existence of information is not a problem for pharma. The challenge is in how to gather the data, access it, and process it.

Fueled by the strong financial performance of Pharma Services, Diagnostics and Tools, and Digital Health companies and accelerated by the COVID-19 pandemic, the life sciences industry currently has one of the strongest M&A markets in recent history.

Increasingly complex clinical trials are putting pressure on CROs to expand their service offerings in what has been a historically monolithic space – with diagnostics also continuing to play a more important role in the market.